nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Cerebral ischaemia—Ramipril—type 1 diabetes mellitus	0.041	0.0746	CcSEcCtD
Remifentanil—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.0265	0.0483	CcSEcCtD
Remifentanil—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.0246	0.0449	CcSEcCtD
Remifentanil—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.0211	0.0384	CcSEcCtD
Remifentanil—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.0166	0.0302	CcSEcCtD
Remifentanil—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.0158	0.0287	CcSEcCtD
Remifentanil—Amnesia—Ramipril—type 1 diabetes mellitus	0.0153	0.0279	CcSEcCtD
Remifentanil—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.0152	0.0276	CcSEcCtD
Remifentanil—Renal impairment—Ramipril—type 1 diabetes mellitus	0.0151	0.0275	CcSEcCtD
Remifentanil—Dysphagia—Ramipril—type 1 diabetes mellitus	0.0124	0.0226	CcSEcCtD
Remifentanil—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.0122	0.0223	CcSEcCtD
Remifentanil—Bronchitis—Ramipril—type 1 diabetes mellitus	0.0119	0.0218	CcSEcCtD
Remifentanil—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.0119	0.0217	CcSEcCtD
Remifentanil—Renal failure—Ramipril—type 1 diabetes mellitus	0.0109	0.0198	CcSEcCtD
Remifentanil—Sweating—Ramipril—type 1 diabetes mellitus	0.0106	0.0193	CcSEcCtD
Remifentanil—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00958	0.0175	CcSEcCtD
Remifentanil—Flushing—Ramipril—type 1 diabetes mellitus	0.00923	0.0168	CcSEcCtD
Remifentanil—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00898	0.0164	CcSEcCtD
Remifentanil—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00896	0.0163	CcSEcCtD
Remifentanil—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00888	0.0162	CcSEcCtD
Remifentanil—Erythema—Ramipril—type 1 diabetes mellitus	0.00866	0.0158	CcSEcCtD
Remifentanil—Alfentanil—ALB—type 1 diabetes mellitus	0.0082	0.689	CrCbGaD
Remifentanil—Tremor—Ramipril—type 1 diabetes mellitus	0.00811	0.0148	CcSEcCtD
Remifentanil—Agitation—Ramipril—type 1 diabetes mellitus	0.00796	0.0145	CcSEcCtD
Remifentanil—Syncope—Ramipril—type 1 diabetes mellitus	0.00776	0.0141	CcSEcCtD
Remifentanil—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00761	0.0139	CcSEcCtD
Remifentanil—Cough—Ramipril—type 1 diabetes mellitus	0.00755	0.0138	CcSEcCtD
Remifentanil—Convulsion—Ramipril—type 1 diabetes mellitus	0.0075	0.0137	CcSEcCtD
Remifentanil—Anxiety—Ramipril—type 1 diabetes mellitus	0.00735	0.0134	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00732	0.0133	CcSEcCtD
Remifentanil—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00721	0.0131	CcSEcCtD
Remifentanil—Confusional state—Ramipril—type 1 diabetes mellitus	0.00712	0.013	CcSEcCtD
Remifentanil—Oedema—Ramipril—type 1 diabetes mellitus	0.00707	0.0129	CcSEcCtD
Remifentanil—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00707	0.0129	CcSEcCtD
Remifentanil—Shock—Ramipril—type 1 diabetes mellitus	0.00695	0.0127	CcSEcCtD
Remifentanil—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00693	0.0126	CcSEcCtD
Remifentanil—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00692	0.0126	CcSEcCtD
Remifentanil—Tachycardia—Ramipril—type 1 diabetes mellitus	0.0069	0.0126	CcSEcCtD
Remifentanil—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00686	0.0125	CcSEcCtD
Remifentanil—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00683	0.0124	CcSEcCtD
Remifentanil—Hypotension—Ramipril—type 1 diabetes mellitus	0.0066	0.012	CcSEcCtD
Remifentanil—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00634	0.0116	CcSEcCtD
Remifentanil—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.0063	0.0115	CcSEcCtD
Remifentanil—Somnolence—Ramipril—type 1 diabetes mellitus	0.00628	0.0114	CcSEcCtD
Remifentanil—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00622	0.0113	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.0061	0.0111	CcSEcCtD
Remifentanil—Constipation—Ramipril—type 1 diabetes mellitus	0.00604	0.011	CcSEcCtD
Remifentanil—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00582	0.0106	CcSEcCtD
Remifentanil—Urticaria—Ramipril—type 1 diabetes mellitus	0.00561	0.0102	CcSEcCtD
Remifentanil—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00559	0.0102	CcSEcCtD
Remifentanil—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00521	0.00948	CcSEcCtD
Remifentanil—Pruritus—Ramipril—type 1 diabetes mellitus	0.005	0.0091	CcSEcCtD
Remifentanil—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00483	0.0088	CcSEcCtD
Remifentanil—Dizziness—Ramipril—type 1 diabetes mellitus	0.00467	0.00851	CcSEcCtD
Remifentanil—Vomiting—Ramipril—type 1 diabetes mellitus	0.00449	0.00818	CcSEcCtD
Remifentanil—Rash—Ramipril—type 1 diabetes mellitus	0.00446	0.00811	CcSEcCtD
Remifentanil—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00445	0.00811	CcSEcCtD
Remifentanil—Headache—Ramipril—type 1 diabetes mellitus	0.00443	0.00806	CcSEcCtD
Remifentanil—Nausea—Ramipril—type 1 diabetes mellitus	0.0042	0.00764	CcSEcCtD
Remifentanil—Pethidine—ALB—type 1 diabetes mellitus	0.00369	0.311	CrCbGaD
Remifentanil—OPRD1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00249	0.00566	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00246	0.0056	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00245	0.00558	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00242	0.00551	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00242	0.00551	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00237	0.00539	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00234	0.00533	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00231	0.00525	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00228	0.00518	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00226	0.00516	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00225	0.00513	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00221	0.00502	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00218	0.00497	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00218	0.00497	CbGpPWpGaD
Remifentanil—OPRD1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00217	0.00495	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00211	0.00481	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CXCL10—type 1 diabetes mellitus	0.00208	0.00473	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00207	0.00473	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00205	0.00467	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00198	0.00452	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00198	0.0045	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00196	0.00447	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00195	0.00444	CbGpPWpGaD
Remifentanil—OPRK1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00191	0.00434	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00188	0.00428	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00186	0.00425	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00184	0.0042	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00184	0.0042	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—CD4—type 1 diabetes mellitus	0.00184	0.00419	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00183	0.00418	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00175	0.00399	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00173	0.00395	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00172	0.00393	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00172	0.00392	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00172	0.00391	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.0017	0.00388	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL1B—type 1 diabetes mellitus	0.0017	0.00387	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00168	0.00382	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00167	0.0038	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00165	0.00376	CbGpPWpGaD
Remifentanil—OPRM1—Peptide ligand-binding receptors—CCR5—type 1 diabetes mellitus	0.00161	0.00367	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00161	0.00366	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00154	0.0035	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00151	0.00344	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.0015	0.00343	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00149	0.0034	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00146	0.00332	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00146	0.00331	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00143	0.00326	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00142	0.00324	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00141	0.0032	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00139	0.00318	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00136	0.0031	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00135	0.00307	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00132	0.00301	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00129	0.00294	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00128	0.00291	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00128	0.00291	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00128	0.00291	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00128	0.00291	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00127	0.0029	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00126	0.00287	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00126	0.00286	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00125	0.00284	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00123	0.00281	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.0012	0.00273	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00119	0.0027	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00116	0.00264	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00114	0.00259	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00113	0.00258	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00112	0.00255	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00112	0.00255	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00111	0.00253	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00111	0.00253	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00108	0.00246	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00108	0.00245	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00106	0.00242	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00105	0.0024	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00105	0.0024	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00104	0.00237	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00104	0.00237	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00101	0.0023	CbGpPWpGaD
Remifentanil—OPRM1—TCR Signaling Pathway—IL6—type 1 diabetes mellitus	0.000995	0.00227	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000979	0.00223	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000974	0.00222	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000974	0.00222	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000973	0.00222	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00097	0.00221	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000957	0.00218	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000946	0.00215	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000946	0.00215	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000945	0.00215	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000889	0.00203	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000885	0.00202	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000884	0.00201	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000881	0.00201	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000879	0.002	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000868	0.00198	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000854	0.00195	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00085	0.00194	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000836	0.0019	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000823	0.00188	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000822	0.00187	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000812	0.00185	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000809	0.00184	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000798	0.00182	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000788	0.0018	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000776	0.00177	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000772	0.00176	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000762	0.00174	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000761	0.00173	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000759	0.00173	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000754	0.00172	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000754	0.00172	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000747	0.0017	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000737	0.00168	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000735	0.00167	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000733	0.00167	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000722	0.00164	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000719	0.00164	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000712	0.00162	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00071	0.00162	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000709	0.00161	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000691	0.00157	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000669	0.00152	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000666	0.00152	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000661	0.00151	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000661	0.00151	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000656	0.00149	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000653	0.00149	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000646	0.00147	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000645	0.00147	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000643	0.00147	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000636	0.00145	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000628	0.00143	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000622	0.00142	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000619	0.00141	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000619	0.00141	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000602	0.00137	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.0006	0.00137	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000599	0.00136	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000595	0.00136	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000595	0.00136	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000584	0.00133	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00057	0.0013	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000565	0.00129	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000562	0.00128	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000562	0.00128	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000559	0.00127	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000559	0.00127	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000558	0.00127	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00055	0.00125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000546	0.00124	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000545	0.00124	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000542	0.00124	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000525	0.0012	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000525	0.0012	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000523	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000522	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000522	0.00119	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00052	0.00119	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.0005	0.00114	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000493	0.00112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000472	0.00107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000466	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000465	0.00106	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000458	0.00104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000458	0.00104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000456	0.00104	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000448	0.00102	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000444	0.00101	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000441	0.001	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000441	0.001	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000435	0.000992	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000434	0.000989	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000422	0.000962	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000416	0.000948	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000408	0.00093	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000396	0.000902	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000394	0.000898	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000393	0.000896	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000387	0.000882	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000386	0.000878	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000382	0.00087	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000381	0.000867	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00038	0.000865	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000363	0.000826	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00036	0.000821	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000347	0.000791	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000346	0.000788	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000345	0.000786	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000342	0.00078	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000337	0.000767	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000333	0.000758	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000332	0.000757	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000332	0.000756	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000329	0.00075	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000323	0.000735	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000322	0.000733	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000318	0.000724	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000316	0.00072	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.0003	0.000684	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000295	0.000673	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000293	0.000668	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000292	0.000666	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000291	0.000663	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000289	0.000658	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000281	0.000641	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000277	0.000631	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000269	0.000612	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000267	0.000608	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000262	0.000596	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000254	0.000578	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000253	0.000577	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000252	0.000574	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00025	0.000568	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000246	0.00056	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000244	0.000556	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000243	0.000553	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000234	0.000533	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.00023	0.000523	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000229	0.000523	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000222	0.000506	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000221	0.000503	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000205	0.000468	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000205	0.000467	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000201	0.000458	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000195	0.000444	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000195	0.000443	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000194	0.000442	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000194	0.000441	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000188	0.000427	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000187	0.000425	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000173	0.000395	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000171	0.000389	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000171	0.000389	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.00017	0.000387	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.00017	0.000387	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000164	0.000373	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000149	0.000339	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000144	0.000329	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000144	0.000328	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000144	0.000327	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000143	0.000327	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.00013	0.000297	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000121	0.000276	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000114	0.000261	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.00011	0.000251	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—type 1 diabetes mellitus	0.0001	0.000228	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	8.48e-05	0.000193	CbGpPWpGaD
